✦ LIBER ✦
A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human Interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100–300 CD4+ t cells
✍ Scribed by Alberdina W de Boer; Norman Markowitz; H.Clifford Lane; Louis D Saravolatz; Susan L Koletar; Haig Donabedian; Carl Yoshizawa; Anne-Marie Duliege; Gwendolyn Fyfe; Ronald T Mitsuyasu
- Book ID
- 117792882
- Publisher
- Elsevier Science
- Year
- 2003
- Tongue
- English
- Weight
- 109 KB
- Volume
- 106
- Category
- Article
- ISSN
- 1090-2341
No coin nor oath required. For personal study only.